FDA Inspection 1046705 — Prothya Biosolutions Netherlands B.V.
The FDA completed an inspection of Prothya Biosolutions Netherlands B.V. on Mar 30, 2018 in Amsterdam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 30, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Amsterdam (Netherlands)